These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8914801)
1. Immunotherapy for non-Hodgkin's lymphoma. Longo DL Curr Opin Oncol; 1996 Sep; 8(5):353-9. PubMed ID: 8914801 [TBL] [Abstract][Full Text] [Related]
2. Prospects for the management of non-Hodgkin's lymphomas with monoclonal antibodies and immunoconjugates. Press OW Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S19-26. PubMed ID: 9672771 [TBL] [Abstract][Full Text] [Related]
3. Recent advances in antigen-targeted therapy in non-Hodgkin's lymphoma. Feuring-Buske M; Buske C; Unterhalt M; Hiddemann W Ann Hematol; 2000 Apr; 79(4):167-74. PubMed ID: 10834503 [TBL] [Abstract][Full Text] [Related]
6. The potential for immunoconjugates in lymphoma therapy. Liu SY; Press OW Hematol Oncol Clin North Am; 1997 Oct; 11(5):987-1006. PubMed ID: 9336727 [TBL] [Abstract][Full Text] [Related]
7. Adoptive immunotherapy for Hodgkin's lymphoma. Kennedy-Nasser AA; Bollard CM; Rooney CM Int J Hematol; 2006 Jun; 83(5):385-90. PubMed ID: 16787867 [TBL] [Abstract][Full Text] [Related]
8. Current treatment and immunotherapy of Hodgkin's lymphoma. Klimm B; Schnell R; Diehl V; Engert A Haematologica; 2005 Dec; 90(12):1680-92. PubMed ID: 16330443 [TBL] [Abstract][Full Text] [Related]
9. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma. Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245 [TBL] [Abstract][Full Text] [Related]
10. Antibody-targeted immunotherapy for treatment of non-Hodgkin's lymphoma. White CA; Berlfein JR; Grillo-López AJ Curr Pharm Biotechnol; 2000 Dec; 1(4):303-12. PubMed ID: 11467328 [TBL] [Abstract][Full Text] [Related]
11. [Monoclonal antibodies and immunoconjugates: new prospects in the treatment of non-Hodgkin's lymphomas]. Sack A; Meusers P Strahlenther Onkol; 1999 Apr; 175(4):192-3. PubMed ID: 10230466 [No Abstract] [Full Text] [Related]
13. Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches. Jurcic JG; Cathcart K; Pinilla-Ibarz J; Scheinberg DA Curr Opin Hematol; 2000 Jul; 7(4):247-54. PubMed ID: 10882181 [TBL] [Abstract][Full Text] [Related]
14. [Monoclonal antibody immunotherapy for malignant non-Hodgkin's lymphoma]. Jourdan E; Richard B Presse Med; 2000 Apr; 29(13):717-21. PubMed ID: 10797826 [TBL] [Abstract][Full Text] [Related]
15. Therapy of B-cell lymphomas with monoclonal antibodies and radioimmunoconjugates: the Seattle experience. Johnson TA; Press OW Ann Hematol; 2000 Apr; 79(4):175-82. PubMed ID: 10834504 [TBL] [Abstract][Full Text] [Related]
16. Rituximab immunotherapy for non-Hodgkin's lymphoma. White CA Cancer Biother Radiopharm; 1999 Aug; 14(4):241-50. PubMed ID: 10850310 [TBL] [Abstract][Full Text] [Related]
17. Antibody and immunomodulatory agents in the treatment of indolent non-Hodgkin's lymphoma. LaCasce AS; Freedman AS Semin Hematol; 2008 Apr; 45(2):85-9. PubMed ID: 18381102 [TBL] [Abstract][Full Text] [Related]